A manuscript co-authored by Nate Johnson and Chris Evans reports on our continued work in the field of respiratory diseases and our effort to support Jeff Swigris, DO at National Jewish Health, Denver, CO in the validation and FDA Drug Development Tool Qualification of the L-PF measure: Swigris J, Andrae DA, Churney T, Johnson N, Scholand MB, White ES, Matsui A, Raimundo K, Evans CJ. Development and initial validation analyses of the living with idiopathic pulmonary fibrosis questionnaire.  American Journal of Respiratory and Critical Care Medicine 2020;12: 1689-1697.